Business, energy, technology, markets and global industry news from Business News Today

neurodegenerative disease diagnostics

PharmaDeviceNews neurodegenerative disease diagnostics
Medical Devices & Diagnostics

What Spear Bio’s new pTau 217 assay reveals about where Alzheimer’s biomarker detection is heading

Spear Bio debuts BD-pTau 217, alpha-synuclein and pS129-a-syn assays at AD/PD 2026. What the claims mean for Alzheimer's and Parkinson's research. Read the analysis.

Read More
C2N Diagnostics expands PrecivityAD2 blood test into South Korea as Alzheimer’s diagnostics market shifts toward earlier detection
Medical Devices & Diagnostics

Can blood-based Alzheimer’s diagnostics change clinical practice? C2N Diagnostics enters South Korea with PrecivityAD2

C2N Diagnostics brings its PrecivityAD2 blood test to South Korea through BeauBrain Healthcare. Discover what this means for Alzheimer’s diagnosis.

Read More